Clinical Trial Update: Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase II study update evaluating a combination of Biaxin, Revlimid, and dexamethasone for untreated multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Biaxin (clarithromycin)
• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED